Related Experiment Video

Updated: Sep 5, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.3K

Patient Adherence to Therapy After Myocardial Infarction: A Scoping Review

Olga Zorina1, Natalja Fatkulina2, Feruza Saduyeva1

  • 1Research School, Karaganda Medical University, Karaganda, Kazakhstan.

Patient Preference and Adherence
|July 11, 2022
PubMed

Insights

Improving medication adherence after myocardial infarction is crucial. Utilizing modern technologies and phone communication significantly enhances patient adherence to cardiac treatments.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Low adherence to secondary prevention strategies is common in patients post-myocardial infarction (MI).
  • Patients often discontinue cardiac medications shortly after hospital discharge due to various factors, leading to poor adherence rates.
  • Effective secondary prevention is vital for reducing re-infarction and improving long-term outcomes in MI survivors.

Purpose of the Study:

  • To identify key factors influencing treatment adherence in patients following a myocardial infarction.
  • To explore the role and effectiveness of interventions aimed at improving medication adherence in this patient population.

Main Methods:

  • A systematic literature search was conducted using two major electronic databases: PubMed and Web of Science.
  • The review focused on published systematic reviews and randomized controlled trials concerning adherence interventions post-MI.
  • The Arksey & O'Malley methodological framework guided the scoping review process.

Main Results:

  • Thirteen articles met the inclusion and exclusion criteria for the review.
  • Four studies analyzed factors affecting patient adherence to therapy post-MI.
  • The remaining studies evaluated diverse interventions designed to enhance treatment adherence.

Conclusions:

  • There is a clear need to enhance treatment adherence among patients recovering from myocardial infarction.
  • Interventions involving modern technologies, such as mobile health applications, show promise in improving adherence.
  • Regular patient communication via telephone is an effective strategy for boosting adherence to cardiac treatments.
Abstract

Keywords:
adherencemyocardial infarctionnursing

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K
Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.1K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
41
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
21
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
23
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27